YZYijun Zhan

Yijun Zhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yijun Zhan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of soluble TREM2 with Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis

    by Ruiqi Wang, Yijun Zhan, Wenyan Zhu, Qianwen Yang, Jian Pei

    Objective: Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) is a potential neuroinflammatory biomarker linked to the pathogenesis of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Previous studies have produced inconsistent results regarding sTREM2 levels in various clinical stages of AD. This study aims to establish the correlation between sTREM2 levels and AD progression through a meta-analysis of sTREM2 levels in cerebrospinal fluid (CSF) and blood.Methods: Comprehensive searches were conducted in PubMed, Embase, Web of Science, and the Cochrane Library to identify observational studies reporting CSF and blood sTREM2 levels in AD patients, MCI patients, and healthy controls. A random effects meta-analysis was used to calculate the standardized mean difference (SMD) and 95% confidence intervals (CIs).Results: Thirty-six observational studies involving 3,016 AD patients, 3,533 MCI patients, and 4,510 healthy controls were included. CSF sTREM2 levels were significantly higher in both the AD [SMD = 0.28, 95% CI (0.15, 0.41)] and MCI groups [SMD = 0.30, 95% CI (0.13, 0.47)] compared to the healthy control group. However, no significant differences in expression were detected between the AD and MCI groups [SMD = 0.09, 95% CI (−0.09, 0.26)]. Furthermore, increased plasma sTREM2 levels were associated with a higher risk of AD [SMD = 0.42, 95% CI (0.01, 0.83)].Conclusion: CSF sTREM2 levels are positively associated with an increased risk of AD and MCI. Plasma sTREM2 levels were notably higher in the AD group than in the control group and may serve as a promising biomarker for diagnosing AD. However, sTREM2 levels are not effective for distinguishing between different disease stages of AD. Further investigations are needed to explore the longitudinal changes in sTREM2 levels, particularly plasma sTREM2 levels, during AD progression.Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024514593


  • Open Access

    The Prognostic Value of Traditional Chinese Medicine Symptoms in Acute Ischemic Stroke: A Pilot Study

    by Jia Xu, Jian Pei, Qin-Hui Fu, Yi-Jun Zhan

    Background. Stroke scales of traditional Chinese medicine (SSTCM) are promoted for use in the early prognosis. The current lines of evidence to support their performance evaluation are uneven. This pilot study aimed to investigate the correlation between traditional Chinese medicine (TCM) symptoms in the early stages of acute ischemic stroke and the prognosis of motor dysfunction through one‐year of follow‐up. Methods. Three hundred and fifteen patients were retrospected at Longhua Hospital from January 2016 to December 2017. All patients had received standard treatments combined with acupuncture therapy, including both electroacupuncture and scalp acupuncture for a median course of five months. The observed outcomes were the Fugl‐Meyer assessment (FMA), the modified Barthel index (MBI), and the modified Rankin scale (mRS) at one‐year follow‐up after stroke onset by multiple linear regression analysis combined with ROC curves. Results. The favorable outcome rate was 74.3%, with the recurrence rate of 20.3% in the follow‐up. In multiple linear regression, 10 TCM symptoms (MBI regression model) were related to the prognosis of MBI (DW 1.409, Ad. R2 0.654) and 10 TCM symptoms (FMA regression model) were related to the FMA outcome (DW 1.446, Ad R2 0.620). The two models were selected to have nine repeated symptoms (repeated model). In the ROC curves, the three models were compared with the NIHSS score, and the MBI regression model reflected the highest efficiency. Conclusions. The combination of 10 TCM symptoms, once onset occurred, including hemiplegia, restlessness, hemianesthesia, short breath, headache, constipation, night sweat, tinnitus, thirsty, and gurgling with sputum, may affect the recovery of motor dysfunction. Furthermore, the improvements of TCM symptoms dynamically after treatment would be observed in a large prospective cohort. This trial is registered with NCT01806233.


  • Seatbelt Recognition Method Based on Convolutional Attention Mechanism

    by Guangxi Chen, Fangfang Lv, Yijun Zhan, Yong Huang

    In order to solve the problem of low accuracy of the driver's seat-belt identification and neglecting co-pilot, a method of driver's seat-belt identification based on deep convolutional channel modeling is improved. Firstly, the characteristic parameters of redundant channels are reduced by means of deep convolutional feature channel compression. Then, the feature weight of the deep convolutional channel is re-calibrated to improve the attention weight of the feature of the safety belt and suppress the expression of the interference feature. Finally, the central loss function is used to assist feature training of the model, so as to reduce the difference of feature distribution within the class and make the learned features easier to be classified and recognized. The experimental results show that, compared with other algorithms, the improved deep convolution driver seat belt identification model in this paper improves the recognition accuracy, recall rate, and F value by 6.9%, 4.32 and 5.5% respectively, and greatly improves the accuracy and practicability.